Side-by-side financials for CMPX and AMGN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CMPX | AMGN |
|---|---|---|
| Market cap | - | $190.92 B |
| US-listed rank | - | #79 |
| Revenue (latest FY) | $0.00 | $36.75B |
| Net income (latest FY) | -$66.49M | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 24.8 |
| SEC filings | 349 | 1,011 |
In their latest fiscal years, Compass Therapeutics, Inc. reported $0.00 in revenue while AMGEN INC reported $36.75B.
Full pages: Compass Therapeutics, Inc. and AMGEN INC, or browse the full rankings.